Philmans Pharm, Cenedella.de, The German Patient Roundtable

Est. 1977

European Parliament Hosts International Conference on Medical Cannabis

European Parliament Hosts International Conference on Medical Cannabis
By Bill Griffin on Dec 07, 2016 09:28 am
european-parliament-holds-international-conference-on-medical-marijuana

On November 24th, the European Parliament in Brussels hosted its first international conference on medical cannabis. Cannabis experts, doctors, patients and representatives of the cannabis industry in Europe gathered to attend the three hour event.

It was an icy cold day and my car informed me that it was -4 degrees Celsius as I made my way into Brussels. Thankfully, the sun was shining. Colleagues (as we all work for the plant) and friends that I have been picking up along the way from the cannabis industry were converging in “the belly of the beast” to have a sensible conversation as to how medical cannabis is going to work in Europe.

european-parliament-holds-international-conference-on-medical-marijuana-brussels
European Parliament hosts International Conference on Medical Cannabis. Image Credit: Bill Griffin

Responsibility to provide safe access

Saul Kaye, CEO of iCan, couldn’t have summed the situation up better: “It’s not a matter of if, but when and how you make safe medical cannabis available in Europe. The industry is coming and it will make a lot of money. Not giving patients access to cannabis is negligence on behalf of regulators and they have a responsibility to provide this safe access, not to block it.”

Opening the conference, MEP Stelios Kouloglou spoke of how cannabis leads to economic growth. “Cannabis is the fastest growing sector of the US and Israeli economies. The EU has been left behind.” With regards to health he said, “We want to save lives, we know cannabis can help with many serious diseases. We shouldn’t act like we are in the dark ages and be guided by outdated laws from last century but must be guided by science.”

Introducing the first of two panels, Graham De Barra of Help not Harm, an organization supporting a realistic, evidence-based approach to drug policy in Ireland, reminded us that “we must integrate people into health services and away from the harmful black market”.

Doctors in the house

Well represented on the panels of the day were practitioners who had positive results with medical cannabis for their patients. Dr. Dominique Lossignol, who is a specialist in cancer and pain treatment, prescribes medical cannabis to patients in Belgium. He explained that the human body produces a huge amount of cannabinoids and that “there is a gap in our current medicine, and that gap is cannabinoids. We need them for the best treatment of pain.”

european-parliament-holds-international-conference-on-medical-marijuana-panel-two
Dr. Franjo Grotenhemen (on hospital bed) addresses the conference. Panel two (from left): Petros Evokes, Manuel Guzman, MEP Katerina Konecna, Carola Perez, Saul Kaye. Image Credit: Bill Griffin

Dr. Franjo Grotenhemen, President of the International Association for Cannabinoids as Medicine and Chairman of the Medical Cannabis Declarationin Germany spoke of our “fundamental human right to good health.” Dr. Grotenhemen, who was speaking from a hospital stretcher for reasons that were not mentioned, said, “Patients have the right and the ability to treat themselves and we don’t allow it.”

He concluded with a powerful statement that makes things so clear, “Patients should have the right to access cannabis and doctors should have the right to prescribe it.”

Scientific evidence

“The next revolution in medical cannabis is science,” explained Pavel Kubu, Director of the International Cannabis and Cannabinoids Institute. He described the work of ICCI in “unlocking the database of nature” through the utilisation of big data and tools and the work of ICCI in providing Patient Focused Certification across Europe.

Globally we have made so many gains in recent years under extremely restrictive conditions, yet we are not even scratching the surface of the benefits that this amazing plant can offer. Imagine how things will change when we allow our great institutes of science to explore cannabis further as they see fit.

Patient patience is running out

Listening to politicians, doctors and scientists is great, but you have to remember it is patients from all ages and walks of life who are suffering due to the dis-harmonisation of laws and regulations across Europe when it comes to medical cannabis and cannabis research.

european-parliament-holds-international-conference-on-medical-marijuana-panel-one
Panel one (from left): Pavel Kubu, Majda Robić, Giorgos Oikonomopoulos, Graham De Barra, MEP Stelios Kouloglox, Alessandro Piccioli, Dimos Fotopoulos, Dominique Lossignol, Bertrand Rambaud. Image Credit: Bill Griffin

Patient testimonials snap us right back into the reality and the urgency of the situation we are in. People are literally dying because they cannot get access to cannabis through their health systems.

One panellist spoke of patients dying with their medical cannabis prescription in hand without ever obtaining their medicine. This is the cruel consequence of global law’s inability to catch up with knowledge that is spreading around the world at the speed of a mouse click; doubly so as the laws were put into place under suspect circumstances.

CBD for Ava

We heard from several patients and caregivers on how cannabis has helped their situation. By far the most moving account was from a brave mother of four, Vera Twomey from Barry in Ireland. Vera’s little girl Ava suffers from dravet syndrome – which is a severe form of epilepsy that affects an estimated 1 in every 20,000–40,000 births. There was not a dry eye in the forum as Vera described how she was told that her baby would never talk or walk. Vera described how specialists had laughed at her when she dared to suggest her child would walk.

She recalled how seven seizures every two hours would cripple the body of poor Ava. As soon as she was able to get her daughter CBD oil the seizures had reduced to only seven in one entire month. That’s a whopping 92% decrease. She’s now attending school and walking, talking and even dancing. I tell you, put lovely Vera in the room with all those standing in the way of legal, medical cannabis-derived products getting to the patients that need them, and things will soon be resolved.

At the time of this writing, Vera’s petition to the Irish Minister of Health is just shy of the 25,000 signatures it needs. If you have a heart, please sign.

Homegrown is not medicine

I learned that there is and needs to be a distinction between homegrown and medical cannabis. Medicine is not easy to bring to market and there are many mechanisms to ensure safety. The level of cleanliness and documentation that goes into creating the medicine you get from your pharmacy goes beyond what many can possibly imagine.

Though often jeered at from the cannabis community, Bedrocan actually offers dried cannabis flower that adheres to the necessary requirements needed to get a “drug” distributed through existing pharmacies. Even in Germany – where strict adherence to regulations is an art form. That is a major achievement for the Dutch company.

Decriminalising the ability for someone to grow their own plant is not providing them medicine. You can produce aspirin from the bark of a willow tree, but how would you react if your doctor gave you a prescription telling you to do just that?

Human rights are being seriously abused here and we urgently need to collectively work towards a system that gives people safe access to cannabis.

Closing the conference, MEP Stefan Eck spoke of how a topic that had once been so taboo is now provoking so much conversation. He said, “Cannabis has been used for centuries and it is time to legalise now for use in Europe.”

The amount of panelists and speakers within such a short timeframe was intense, to say the least. It was like a three day medical and scientific conference had sex with a speed dating event and gave birth to this conference in the EU Parliament, which transpired over a few short hours. Though a little manic in speed the end result left me feeling very optimistic on cannabis being – at the very least – available to those who need it most in as safe a manner as possible.

Author: Cenedella.de

Over the last 4 decades I have been involved in the fight for patient rights in America, and now here in Germany. During my career I have served as a Board of Director for the World Trade Center San Diego and as a Lead Consultant for Deutsche Telekom's Executive Board, Co-Founded the San Diego Software Council and the Dayton Human Trafficking Accords and was Director of LawInfo's Lead Council Program. Previously I was a C-Level Business Development Executive in the technology sector, but also involved with the cannabis industry since 1977. More recently I have been fulltime in the legal medical marijuana industry here in Europe, helping international companies navigate the biggest potential market in the world. This website is light on details due to confidentiality issues with clients but be rest assured I am knowledgeable, professional and with street cred in the industry that can immediately assist your growth in some way. Consulting Services: Sales and Business Development Assist with Strategic Direction Professionally represent your firm Special Projects management Licensing and compliance Sales and Distribution networks Qualify potential partners I am your resource on the ground in Europe, contact me directly to schedule an initial discussion on the German Cannabis-as-Medicine market. Thank you, Philip J. Cenedella IV Call +1.888.206.3264 USA +49.0.151.720.17652 GERMANY Skype: philip.j.cenedella eMail: phil@cenedella.de LinkedIN: https://www.linkedin.com/in/cenedellade/

Comments are closed.